Your browser doesn't support javascript.
loading
ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer.
Wang, Junjian; Zou, June X; Xue, Xiaoqian; Cai, Demin; Zhang, Yan; Duan, Zhijian; Xiang, Qiuping; Yang, Joy C; Louie, Maggie C; Borowsky, Alexander D; Gao, Allen C; Evans, Christopher P; Lam, Kit S; Xu, Jianzhen; Kung, Hsing-Jien; Evans, Ronald M; Xu, Yong; Chen, Hong-Wu.
Afiliación
  • Wang J; Department of Biochemistry and Molecular Medicine, School of Medicine, University of California, Davis, Sacramento, California, USA.
  • Zou JX; Department of Biochemistry and Molecular Medicine, School of Medicine, University of California, Davis, Sacramento, California, USA.
  • Xue X; Institute of Chemical Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  • Cai D; Department of Biochemistry and Molecular Medicine, School of Medicine, University of California, Davis, Sacramento, California, USA.
  • Zhang Y; Institute of Chemical Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  • Duan Z; Department of Biochemistry and Molecular Medicine, School of Medicine, University of California, Davis, Sacramento, California, USA.
  • Xiang Q; Institute of Chemical Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  • Yang JC; Department of Urology, School of Medicine, University of California, Davis, Sacramento, California, USA.
  • Louie MC; Department of Natural Sciences and Mathematics, Dominican University of California, San Rafael, California, USA.
  • Borowsky AD; Department of Pathology and Laboratory Medicine, School of Medicine, University of California, Davis, Sacramento, California, USA.
  • Gao AC; Department of Urology, School of Medicine, University of California, Davis, Sacramento, California, USA.
  • Evans CP; Comprehensive Cancer Center, University of California, Davis, Sacramento, California, USA.
  • Lam KS; Department of Urology, School of Medicine, University of California, Davis, Sacramento, California, USA.
  • Xu J; Comprehensive Cancer Center, University of California, Davis, Sacramento, California, USA.
  • Kung HJ; Department of Biochemistry and Molecular Medicine, School of Medicine, University of California, Davis, Sacramento, California, USA.
  • Evans RM; Comprehensive Cancer Center, University of California, Davis, Sacramento, California, USA.
  • Xu Y; Shantou University Medical College, Shantou, China.
  • Chen HW; Department of Biochemistry and Molecular Medicine, School of Medicine, University of California, Davis, Sacramento, California, USA.
Nat Med ; 22(5): 488-96, 2016 05.
Article en En | MEDLINE | ID: mdl-27019329
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Androgénicos / Regulación Neoplásica de la Expresión Génica / Miembro 3 del Grupo F de la Subfamilia 1 de Receptores Nucleares / Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Androgénicos / Regulación Neoplásica de la Expresión Génica / Miembro 3 del Grupo F de la Subfamilia 1 de Receptores Nucleares / Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos